Felodipine sustained-release tablet

A gentle and non-alcoholic technology, applied in the field of medicine, can solve the problems of non-constant release rate, not close to constant rate, and not stable blood pressure, so as to improve compliance, uniform release rate and reduce blood pressure fluctuations Effect
CN107982236AInactive Publication Date: 2018-05-04SOUTHWEST MEDICAL UNIVERISTY +1
2 Cites 2 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
SOUTHWEST MEDICAL UNIVERISTY
Publication Date
2018-05-04
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention belongs to the technical field of drugs, and relates to a felodipine sustained-release tablet. The felodipine sustained-release tablet is prepared from the following components in weightby percent: 1 to 5% of felodipine, 5 to 20% of hydroxypropyl methylcellulose, 1 to 10% of hydroxypropyl cellulose, 10 to 40% of hydrophobic fillers, 40 to 70% of hydrophilic fillers, and 5 to 20% ofother pharmaceutical excipients. The felodipine sustained-release tablet can make release degree of the drugs more uniform at a constant speed.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of medicines, in particular to a felodipine slow-release tablet. Background technique

[0002] Felodipine, chemical name is (±)-2,6-Dimethyl-4-(2,3-dichlorophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate ethyl ester , the English name is FELODIPINE, the molecular formula is C18H19Cl2NO4, the molecular weight is 384.25, and the chemical structure is as follows:

[0003]

[0004] It is white to light yellow crystal or crystalline powder; odorless, tasteless; unstable when exposed to light; easily soluble in acetone, methanol or ethanol, almost insoluble in water.

[0005] Felodipine is a new type of dihydropyridine calcium channel blocker with a high degree of vascular selectivity, with a selectivity ratio of 100 for blood vessels and heart. Lowers arterial pressure by lowering peripheral vascular resistance, has no direct effect on myocardial contractility and cardiac conduction within the therapeutic dose...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More